Cargando…
The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro
BACKGROUND: Fragile X syndrome (FXS), the leading cause of inherited mental retardation, is due to expansion and methylation of a CGG sequence in the FMR1 gene, which result in its silencing and consequent absence of FMRP protein. This absence causes loss of repression of metabotropic glutamate rece...
Autores principales: | Tabolacci, Elisabetta, Pirozzi, Filomena, Gomez-Mancilla, Baltazar, Gasparini, Fabrizio, Neri, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320553/ https://www.ncbi.nlm.nih.gov/pubmed/22397687 http://dx.doi.org/10.1186/1471-2350-13-13 |
Ejemplares similares
-
Progress toward therapeutic potential for AFQ056 in Fragile X syndrome
por: Sourial, Mary, et al.
Publicado: (2013) -
Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease: a meta-analysis
por: Negida, Ahmed, et al.
Publicado: (2021) -
Longitudinal PET studies of mGluR5 in FXS using an FMR1 knockout mouse model
por: Afshar, Sepideh, et al.
Publicado: (2022) -
Mechanisms of the FMR1 Repeat Instability: How Does the CGG Sequence Expand?
por: Tabolacci, Elisabetta, et al.
Publicado: (2022) -
The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice
por: Veloz, M F Vinueza, et al.
Publicado: (2012)